Welltower (WELL)
(Delayed Data from NYSE)
$101.29 USD
+0.34 (0.34%)
Updated May 17, 2024 03:59 PM ET
After-Market: $101.27 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Price, Consensus and EPS Surprise
WELL 101.29 +0.34(0.34%)
Will WELL be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for WELL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for WELL
Rayonier (RYN) Q1 Earnings Beat Estimates, Revenues Lag
Welltower (WELL) Q1 FFO Beat Estimates, Same Store NOI Rises
WELL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Compared to Estimates, Welltower (WELL) Q1 Earnings: A Look at Key Metrics
Welltower (WELL) Q1 FFO and Revenues Beat Estimates
UDR Readies to Report Q1 Earnings? What's in the Offing?
Other News for WELL
Surprise Spring Slowdown
Real estate stocks continue to surge as soft inflation reports fuel rate cut hopes
Winners Of REIT Earnings Season
Welltower price target raised by $12 at Scotiabank, here's why
HEALWELL AI Participates in Leading-Edge Research on Chronic Kidney Disease Highlighting the Potential of its AI Powered Clinical Co-Pilot